Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian P Bates

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Plos One|February 27, 2016
Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease MiceRaffaella Tulino, Agnesska C Benjamin, Nelly Jolinon, et al.
Plos One|December 25, 2013
Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's diseaseIvan Rattray, Edward J Smith, William R Crum, et al.
Plos One|January 28, 2016
SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease MiceRaffaella Tulino, Agnesska C Benjamin, Nelly Jolinon, et al.
Scientific Reports|August 1, 2018
In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's diseaseJeffrey Pido-Lopez, Ralph Andre, Agnesska C Benjamin, et al.
Scientific Reports|May 12, 2019
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatmentJeffrey Pido-Lopez, Benedict Tanudjojo, Sahar Farag, et al.
Brain : a Journal of Neurology|March 8, 2012
Suppression of protein aggregation by chaperone modification of high molecular weight complexesJohn Labbadia, Sergey S Novoselov, John S Bett, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
DNA instability in postmitotic neuronsRoman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Plos One|January 19, 2017
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's DiseaseIvan Rattray, Edward J Smith, William R Crum, et al.
Plos One|June 2, 2009
Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's diseaseCaroline L Benn, Rachel Butler, Lydia Mariner, et al.
Plos One|December 6, 2011
SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's diseaseMichal Mielcarek, Caroline L Benn, Sophie A Franklin, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Plos One|February 27, 2016
Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease MiceRaffaella Tulino, Agnesska C Benjamin, Nelly Jolinon, et al.
Plos One|December 25, 2013
Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's diseaseIvan Rattray, Edward J Smith, William R Crum, et al.
Plos One|January 28, 2016
SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease MiceRaffaella Tulino, Agnesska C Benjamin, Nelly Jolinon, et al.
Scientific Reports|August 1, 2018
In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's diseaseJeffrey Pido-Lopez, Ralph Andre, Agnesska C Benjamin, et al.
Scientific Reports|May 12, 2019
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatmentJeffrey Pido-Lopez, Benedict Tanudjojo, Sahar Farag, et al.
Brain : a Journal of Neurology|March 8, 2012
Suppression of protein aggregation by chaperone modification of high molecular weight complexesJohn Labbadia, Sergey S Novoselov, John S Bett, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
DNA instability in postmitotic neuronsRoman Gonitel, Hilary Moffitt, Kirupa Sathasivam, et al.
Plos One|January 19, 2017
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's DiseaseIvan Rattray, Edward J Smith, William R Crum, et al.
Plos One|June 2, 2009
Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's diseaseCaroline L Benn, Rachel Butler, Lydia Mariner, et al.
Plos One|December 6, 2011
SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's diseaseMichal Mielcarek, Caroline L Benn, Sophie A Franklin, et al.
Pageof 15